Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: A H215O positron emission tomography study

Clinical Science

Volumn 93, Issue 2, 1997, Pages 159-165

  Schellong, Sebastian M ^a,b   Böger, Rainer H ^a   Burchert, Wolfgang ^a   Bode Böger, Stefanie M ^a   Galland, Andrea ^a   Frölich, Jürgen C ^a   Hundeshagen, Heinz ^a   Alexander, Klaus ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Cyclic GMP; L arginine; Nitric oxide; Positron emission tomography; Skeletal muscle

Indexed keywords

ARGININE; CYCLIC GMP; NITRIC OXIDE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; GASTROCNEMIUS MUSCLE; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MUSCLE BLOOD FLOW; PERIPHERAL VASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VASODILATATION;

EID: 0030742704     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930159     Document Type: Article

References (42)

1. Leaf CD, Wishnok JS, Tannenbaum SR. L-Arginine is a precursor for nitrate biosynthesis in humans. Biochem Biophys Res Commun 1989; 163: 1032-7.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 1987; 327: 524-6.
3. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986; 78: 1-5.
4. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375-8.
5. Förstermann U, Dudel C, Frölich JC. Endothelium-derived relaxing factor is likely to modulate the tone of resistance arteries in rabbit hindlimb in vivo. J Pharmacol Exp Therapeutics 1988; 243: 1055-61.
6. Creager MA, Cooke JP, Mendelsohn MD, Gallagher SG, Coleman SM, Loscalzo J, Dzau DJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-34.
7. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol 1994; 23: 844-50.
8. Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich FC. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995; 117: 273-84.
9. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990; 67: 1301-8.
10. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-72.
11. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki F-M, Alexander K, Frölich JC. L-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994; 87: 303-10.
12. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90: 1248-53.
13. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-50.
14. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frölich JC. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia: a randomized, controlled study. Circulation 1996; 93: 85-90.
15. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25: 918-23.
16. Ranke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander K. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound 1992; 20: 187-93.
17. Raichle ME, Martin WRW, Herscovitch P, Mintun MA, Markham J. Brain blood flow measured with intravenous H2150. II Implementation and validation. J Nucl Med 1983; 24: 790-8.
18. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Non-invasive quantitation of myocardial blood flow in human subjects with oxygen-15-labelled water and positron emission tomography. J Am Coll Cardiol 1989; 14: 639-52.
19. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-48.
20. Burchert W, Schellong SM, van den Hoff J, Meyer GJ, Alexander K, Hundeshagen H. Oxygen-15-water PET assessment of muscular blood flow in peripheral vascular disease. J Nucl Med 1997; 38: 93-8.
21. Kety SS, Schmidt CE. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948; 27: 476-83.
22. van den Hoff J, Burchert W, Müller-Schauenburg W, Meyer GJ, Hundeshagen H. Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization. J Nucl Med 1993; 34: 1770-7.
23. 22a. Bode-Böger SH, Böger RH, Kienke S, Junker W, Frölich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996; 219: 598-603.
24. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, Takeshita A. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992; 20: 511-7.
25. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991; 81: 695-700.
26. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87: 1475-81.
27. 15O. Circulation 1984; 70: 724-33.
28. Nuutila P, Raitakari M, Laine H, Kirvelä O, Takala T, Utriainen T, Mäkimattila S, Pitkänen O-P, Ruotsalainen U, Iida H, Knuuti J, Yki-Järvinen H. Role of blood flow in regulating insulin-stimulated glucose uptake in humans. J Clin Invest 1996; 97: 1741-7.
29. Schellong SM, Selberg O, Burchert W, van den Hoff J, Creutzig A, Müller MJ, Meyer GJ, Hundeshagen H, Alexander K. Positron emission tomography for measurement of nutritive capillary flow in the muscles of the lower extremity (Abstract). Int J Microcirc 1994; 14: 178.
30. Böger RH, Bode-Böger SM, Gerecke U, Frölich JC. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulate urinary nitrate and cyclic GMP excretion in rats: correlation with vascular reactivity. Cardiovasc Res 1994; 28: 494-9.
31. - excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats. Clin Exp Pharmacol Physiol 1996; 23: 11-15.
32. Radziszewski W, Chopra M, Zembovicz A, Gryglewski R, Ignarro LJ, Chaudhuri G. Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins. Int J Cardiol 1995; 51: 211-20.
33. Schini V, Schoeffer P, Miller RC. Effect of endothelium on basal and stimulated accumulation and efflux of cyclic GMP in isolated rat aorta. Br J Pharmacol 1989; 97: 853-65.
34. Burton GA, MacNeil S, de Jonge A, Haylor J. Cyclic GMP release and vasodilation induced by EDRF and atrial natriuretic factor in the isolated perused kidney of rat. Br J Pharmacol 1990; 99: 364-8.
35. Nakaki I, Hishakawa K, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension (Letter). Lancet 1990; ii: 696.
36. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F. L-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992; 19: 619-25.
37. Baudouin SV, Bath P, Martin JF, Du Bois R, Evans TW. L-Arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. J Clin Pharmacol 1993; 36: 45-9.
38. Lindblom L, Arfors KE. On the relationship between arteriolar flow distribution and capillary flow in skeletal muscle. In: Hammersen F, Messmer K, eds. The microcirculation of skeletal muscle. Basel: Karger, 1984: 90-9.
39. Granger HJ, Goodman AH, Cook BH. Metabolic models of microcirculatory regulation. Federation Proc 1975; 34: 2025-30.
40. Ekelund U, Mellander S. Role of endothelium-derived nitric oxide in the regulation of tonus in large-bore arterial resistance vessels, arterioles and veins in cat skeletal muscle. Acta Physiol Scand 1990; 140: 301-9.
41. 1 or intravenous pentoxifylline during training. Circulation 1994; 90: 818-22.
42. 2 and mimetics in patients with peripheral vascular disease. Prog Clin Biol Res 1989; 301: 85-96.